BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7530703)

  • 1. Reply to editorial by Dr. Earle.
    Fuller LM
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):435-6. PubMed ID: 7530703
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
    Copson E
    Clin Evid; 2005 Jun; (13):1-18. PubMed ID: 16135258
    [No Abstract]   [Full Text] [Related]  

  • 3. Involved-lesion radiation therapy after chemotherapy in limited-stage head-and-neck diffuse large B cell lymphoma.
    Yu JI; Nam H; Ahn YC; Kim WS; Park K; Kim SJ
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):507-12. PubMed ID: 20056353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
    Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of primary gastric diffuse large B cell lymphoma: a retrospective study of 75 cases in China.
    Wu YX; Liu B; Chen L; Li JH; Chen SQ
    Ann Hematol; 2013 Jun; 92(6):861-2. PubMed ID: 23238898
    [No Abstract]   [Full Text] [Related]  

  • 6. Don't treat a relative? I'm glad I did.
    Chevlen EM
    Med Econ; 2000 May; 77(9):159-60, 163, 166. PubMed ID: 10947440
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
    Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E
    Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHOP chemotherapy as standard therapy for treatment of patients with diffuse histiocytic lymphoma.
    Fisher RI
    Important Adv Oncol; 1990; ():217-25. PubMed ID: 2182520
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
    Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
    Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of diffuse large B-cell lymphomas.
    Pfreundschuh M
    Eur J Cancer; 2009 Sep; 45 Suppl 1():386-7. PubMed ID: 19775641
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiation therapy after R-CHOP for diffuse large B-cell lymphoma: the gain remains.
    Yahalom J
    J Clin Oncol; 2010 Sep; 28(27):4105-7. PubMed ID: 20713874
    [No Abstract]   [Full Text] [Related]  

  • 12. Relapsed diffuse large B-cell lymphoma--10 years later.
    Jain S; Shah N; Gregory S
    Clin Adv Hematol Oncol; 2011 Sep; 9(9):704-8. PubMed ID: 22402517
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab plus CHOP for diffuse large-B-cell lymphoma.
    Akhtar S; Maghfoor I
    N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intestinal lymphoma. A report of 2 cases].
    Breda E; Temperilli L
    Minerva Med; 1992 Apr; 83(4):223-5. PubMed ID: 1374168
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV-related lymphoma treated with maintenance thalidomide.
    Larson ML; Enschede SH; Gregory SA
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):231-4; discussion 234-5. PubMed ID: 16166993
    [No Abstract]   [Full Text] [Related]  

  • 16. Lactic Acidosis in Non-Hodgkin's Lymphoma and response to Chemotherapy.
    Osorio S; Bernis C; de La Cámara R
    Haematologica; 2002 Feb; 87(2):ELT05. PubMed ID: 11836182
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Fabbri A; Gozzetti A; Rigacci L
    Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of diffuse large cell lymphoma treated with combination chemotherapy of CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) and BEMP (bleomycin, etoposide, mitoxantrone, procarbazine) with complete remission].
    Itoh T; Sakata Y; Suzuki H; Sugimoto N; Sohma N; Kishibe T; Higuchi S; Seino Y
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):241-4. PubMed ID: 1371049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutropenic fever following chemotherapy in a patient with lymphoma.
    Book L
    Oncol Nurs Forum; 2008 Nov; 35(6):885-7. PubMed ID: 18980919
    [No Abstract]   [Full Text] [Related]  

  • 20. Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP.
    Bosly A; Bron D; Van Hoof A; De Bock R; Berneman Z; Ferrant A; Kaufman L; Dauwe M; Verhoef G
    Ann Hematol; 2008 Apr; 87(4):277-83. PubMed ID: 17952688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.